| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-13 11:47:38 UTC |
|---|
| Update Date | 2022-03-07 02:57:13 UTC |
|---|
| HMDB ID | HMDB0041914 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Ketophenylbutazone |
|---|
| Description | Ketophenylbutazone, also known as kebuzonum or quebuzona, belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Based on a literature review a significant number of articles have been published on Ketophenylbutazone. |
|---|
| Structure | CC(=O)CCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1 InChI=1S/C19H18N2O3/c1-14(22)12-13-17-18(23)20(15-8-4-2-5-9-15)21(19(17)24)16-10-6-3-7-11-16/h2-11,17H,12-13H2,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 1,2-Diphenyl-4-(gamma-ketobutyl)-3,5-pyrazolidinedione | ChEBI | | 4-(3-Oxobutyl)-1,2-diphenyl-3,5-pyrazolidinedione | ChEBI | | Kebuzonum | ChEBI | | Ketophenylbutazonum | ChEBI | | Quebuzona | ChEBI | | Kebuzone | Kegg | | 1,2-Diphenyl-4-(g-ketobutyl)-3,5-pyrazolidinedione | Generator | | 1,2-Diphenyl-4-(γ-ketobutyl)-3,5-pyrazolidinedione | Generator | | Chebutan | HMDB | | Phloguron | HMDB | | Chetofenilbutazone | HMDB | | Copirene | HMDB | | Racheton | HMDB | | Chetofenilbutazon | HMDB | | Ketazon | HMDB | | Kebuzon | HMDB | | Ketophenylbutazone | ChEBI |
|
|---|
| Chemical Formula | C19H18N2O3 |
|---|
| Average Molecular Weight | 322.3578 |
|---|
| Monoisotopic Molecular Weight | 322.131742452 |
|---|
| IUPAC Name | 4-(3-oxobutyl)-1,2-diphenylpyrazolidine-3,5-dione |
|---|
| Traditional Name | kebuzone |
|---|
| CAS Registry Number | 853-34-9 |
|---|
| SMILES | CC(=O)CCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C19H18N2O3/c1-14(22)12-13-17-18(23)20(15-8-4-2-5-9-15)21(19(17)24)16-10-6-3-7-11-16/h2-11,17H,12-13H2,1H3 |
|---|
| InChI Key | LGYTZKPVOAIUKX-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Benzene and substituted derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Monocyclic benzene moiety
- Pyrazolidinone
- 1,3-dicarbonyl compound
- Pyrazolidine
- Carboxylic acid hydrazide
- Ketone
- Organoheterocyclic compound
- Carboxylic acid derivative
- Azacycle
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Carbonyl group
- Hydrocarbon derivative
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.17 mg/mL at 20 °C | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.9 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 16.7323 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.66 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3268.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 466.6 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 197.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 220.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 311.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 656.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 606.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 72.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1495.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 555.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1668.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 432.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 421.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 282.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 185.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Ketophenylbutazone,1TMS,isomer #1 | CC(=CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C | 2675.9 | Semi standard non polar | 33892256 | | Ketophenylbutazone,1TMS,isomer #1 | CC(=CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C | 2705.7 | Standard non polar | 33892256 | | Ketophenylbutazone,1TMS,isomer #2 | C=C(CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C | 2639.2 | Semi standard non polar | 33892256 | | Ketophenylbutazone,1TMS,isomer #2 | C=C(CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C | 2646.5 | Standard non polar | 33892256 | | Ketophenylbutazone,1TBDMS,isomer #1 | CC(=CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C(C)(C)C | 2914.4 | Semi standard non polar | 33892256 | | Ketophenylbutazone,1TBDMS,isomer #1 | CC(=CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C(C)(C)C | 2904.9 | Standard non polar | 33892256 | | Ketophenylbutazone,1TBDMS,isomer #2 | C=C(CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C(C)(C)C | 2874.1 | Semi standard non polar | 33892256 | | Ketophenylbutazone,1TBDMS,isomer #2 | C=C(CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C(C)(C)C | 2840.8 | Standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Ketophenylbutazone GC-MS (Non-derivatized) - 70eV, Positive | splash10-000x-9451000000-20f6c914fed406957207 | 2017-08-28 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ketophenylbutazone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 10V, Positive-QTOF | splash10-05fr-0019000000-c5e4c3ccd5cce60874be | 2017-07-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 20V, Positive-QTOF | splash10-0avi-4179000000-25bd6883a89d363eb632 | 2017-07-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 40V, Positive-QTOF | splash10-000x-9230000000-5de6d5996d83a5d16f71 | 2017-07-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 10V, Negative-QTOF | splash10-00di-0029000000-7b443a0fcd3e3a5df407 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 20V, Negative-QTOF | splash10-0kmi-5579000000-5ea363b653693ed3125c | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 40V, Negative-QTOF | splash10-0006-9500000000-706ef9e0b02460c9ff45 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 10V, Positive-QTOF | splash10-00di-0009000000-33d59492e0378fd90171 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 20V, Positive-QTOF | splash10-00di-0039000000-36491d2e363fb42d8075 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 40V, Positive-QTOF | splash10-07bf-9800000000-f0dc377845da2da2132c | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 10V, Negative-QTOF | splash10-00di-0009000000-c0122f56c13f37edfeb3 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 20V, Negative-QTOF | splash10-0umi-0194000000-144aa7f826627fd26805 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ketophenylbutazone 40V, Negative-QTOF | splash10-053u-9200000000-9967204f9ae136396b56 | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|
| General References | - SIBLIKOVA O, CERNA M, HAIS IM: [Contribution to the metabolism of ketophenylbutazone. II. Ketophenylbutazone metabolites in urine]. Cesk Farm. 1962 Mar;11:123-6. [PubMed:13912486 ]
- Zhivkova ZD, Russeva VN: Binding of kebuzone to human serum albumin studied by high performance liquid affinity chromatography. Arzneimittelforschung. 2000 Mar;50(3):272-5. [PubMed:10758780 ]
- CUGURRA F, BRAMBILLA G: [Comparison between phenylbutazone and ketophenylbutazone]. Arch Ital Sci Farmacol. 1960 Jul;10:195-207. [PubMed:13718791 ]
- SIBLIKOVA O, VACHEK J, CERNA M, TESAREK B, VITULOVA V: [Contribution to the metabolism of ketophenylbutazone. I]. Cesk Farm. 1962 Mar;11:118-23. [PubMed:13912489 ]
- SALVI V: [CLINICAL EXPERIENCES WITH THE USE OF KETOPHENYLBUTAZONE]. Minerva Med. 1963 Sep 8;54:2554-6. [PubMed:14089873 ]
- Horakova Z, Metys J, Cepelak V: [Influence of phenylbutazone and ketophenylbutazone on the gastrointestinal tract]. Therapie. 1965 May-Jun;20(3):617-30. [PubMed:4953937 ]
- Huvar A, Sitar J, Kubistova J: [Time of onset of changes in the renographic curve following administration of ketophenylbutazone]. Vnitr Lek. 1969 Nov;15(11):1070-5. [PubMed:5364826 ]
- Nielsen GH, Holmen-Christensen H: Plasma concentrations of monophenylbutazone, phenylbutazone and ketophenylbutazone after intravenous administration to rats and mice. Acta Pharmacol Toxicol (Copenh). 1967;25:Suppl 4:42. [PubMed:5630939 ]
- Sitar J: [Further experiences with suppression of anginal pain with ketophenylbutazone]. Vnitr Lek. 1968 Sep;14(9):899-904. [PubMed:5680889 ]
- Huvar A, Sitar J: [Effect of ketophenylbutazone on the renographic tracing examined with hippuran I-131]. Vnitr Lek. 1969 Apr;15(4):326-31. [PubMed:5780934 ]
- Rejholec V: [Some new possibilities for the use of ketophenylbutazone (Ketazon-Spofa) in rheumatology]. Reumatizam. 1966;13(6):205-9. [PubMed:5973922 ]
- Queisnerova M, Siblikova O, Veverkova M, Macek K, Nemecek O: [Biotransformation of ketophenylbutazone in vitro]. Cesk Farm. 1967 Jun;16(5):219-22. [PubMed:6077826 ]
|
|---|